rs34731820
Positions:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2
The ENST00000354638.8(OCA2):āc.1109T>Cā(p.Ile370Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000613 in 1,614,014 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0033 ( 4 hom., cov: 32)
Exomes š: 0.00033 ( 5 hom. )
Consequence
OCA2
ENST00000354638.8 missense
ENST00000354638.8 missense
Scores
8
10
Clinical Significance
Conservation
PhyloP100: 6.22
Genes affected
OCA2 (HGNC:8101): (OCA2 melanosomal transmembrane protein) This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
PM1
In a transmembrane_region Helical (size 16) in uniprot entity P_HUMAN there are 9 pathogenic changes around while only 1 benign (90%) in ENST00000354638.8
BP4
Computational evidence support a benign effect (MetaRNN=0.01856479).
BP6
Variant 15-27990583-A-G is Benign according to our data. Variant chr15-27990583-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 419971.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Likely_benign=1, Uncertain_significance=3}.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OCA2 | NM_000275.3 | c.1109T>C | p.Ile370Thr | missense_variant | 10/24 | ENST00000354638.8 | NP_000266.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OCA2 | ENST00000354638.8 | c.1109T>C | p.Ile370Thr | missense_variant | 10/24 | 1 | NM_000275.3 | ENSP00000346659 | P1 | |
OCA2 | ENST00000353809.9 | c.1045-917T>C | intron_variant | 1 | ENSP00000261276 |
Frequencies
GnomAD3 genomes AF: 0.00334 AC: 508AN: 152206Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
508
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000868 AC: 218AN: 251172Hom.: 0 AF XY: 0.000604 AC XY: 82AN XY: 135756
GnomAD3 exomes
AF:
AC:
218
AN:
251172
Hom.:
AF XY:
AC XY:
82
AN XY:
135756
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000328 AC: 480AN: 1461690Hom.: 5 Cov.: 30 AF XY: 0.000301 AC XY: 219AN XY: 727152
GnomAD4 exome
AF:
AC:
480
AN:
1461690
Hom.:
Cov.:
30
AF XY:
AC XY:
219
AN XY:
727152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00335 AC: 510AN: 152324Hom.: 4 Cov.: 32 AF XY: 0.00311 AC XY: 232AN XY: 74492
GnomAD4 genome
AF:
AC:
510
AN:
152324
Hom.:
Cov.:
32
AF XY:
AC XY:
232
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
121
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Tyrosinase-positive oculocutaneous albinism Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Dec 12, 2017 | The OCA2 c.1109T>C (p.Ile370Thr) missense variant has been reported in one study in which it was found in a compound heterozygous state with a second missense variant in one individual with an unusual hypopigmentation type, and in a heterozygous state in another individual with a skin color resembling that of rufus oculocutaneous albinism, in whom a second variant was not detected (Kerr et al. 2000). The Ile370 residue is conserved. Control data are unavailable for this variant, which is reported at a frequency of 0.025253 in the Esan in Nigeria population of the 1000 Genomes Project. Based on the evidence, the p.Ile370Thr variant is classified as a variant of uncertain significance but suspicious for pathogenicity for oculocutaneous albinism. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
not provided Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 26, 2017 | The I370T variant in the OCA2 gene has been reported previously in two unrelated individuals of African descent with an unusual hypopigmentation phenotype suggestive of oculocutaneous albinism (OCA). The I370T variant was reported along with a second variant in an individual with light brown eyes and yellow-ish white colored hair. The second individual was heterozygous for the I370T variant, with no second variant identified, and had reddish-brown colored skin (Kerr et al., 2000). The I370T variant is observed in 114/10360 (1.1%) alleles from individuals of African background in the ExAC dataset, and no individuals were reported to be homozygous (Lek et al., 2016). The I370T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position where amino acids with similar properties to Isoleucine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret I370T as a variant of uncertain significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 20, 2015 | - - |
OCA2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 01, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Uncertain
D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at